Conduit Pharmaceuticals (CDT) Sees 18.27% Decline on October 3rd, 2023
On October 3rd, 2023, Conduit Pharmaceuticals (CDT) opened at $5.34, but closed at $4.83, marking an 18.27% decline, with a 52-week high of $12.89, a low of $4.44, and a P/E ratio of 1,762.77, amid a market capitalization of approximately $444.27 million USD.
by Rajesh
Updated Oct 04, 2023
Article continues below advertisement
Conduit Pharmaceuticals (CDT) Stock Analysis
On October 3rd, 2023, Conduit Pharmaceuticals(CDT), a major player in the Pharmaceutical industry, witnessed an eventful day in the stock market. The trading session kicked off with an opening price of $5.34, initiating a day marked by market fluctuations and investor attention. Throughout the day, the stock experienced price volatility but eventually settled at $4.83 at the close, indicating a decrease of −$1.08 (18.27%) compared to the previous day's closing value $5.91.
The day's trading range, with a high of $5.34 and a low of $4.44, offered valuable insights into market dynamics, reflecting shifts in investor sentiment and activity. Additionally, the 52-week performance metrics unveiled a 52-week high of $12.89 and a 52-week low of $4.44, showcasing the stock's historical price range over the past year.
This data presents a comprehensive snapshot of Conduit Pharmaceuticals(CDT)'s performance on October 3rd, 2023, serving as a crucial resource for investors and market analysts seeking to assess the company's stock movements and its position within the ever-evolving Pharmaceutical industry.
|
Key Metrics |
Value |
|
Opening Price |
$5.34 |
|
Closing Price |
$4.83 |
|
Market Capitalization |
444.27M USD |
|
P/E Ratio |
1,762.77 |
|
Price Range Today |
|
|
High |
$5.34 |
|
Low |
$4.44 |
|
52-Week Performance |
|
|
52-Week High |
$12.89 |
|
52-Week Low |
$4.44 |
Related Articles
What is Overbought and Oversold?
107 days ago
Disclaimer : The above information is for general informational purposes only. All information on the Site is provided in good faith, however we make no representation or warranty of any kind, express or implied, regarding the accuracy, adequacy, validity, reliability, availability or completeness of any information on the Site.